D. S. Freestone - Concepedia

Author

D. S. Freestone

Also Known As

D FREESTONE, D S Freestone, D. S. FREESTONE, D. S. Freestone, D.S Freestone, D.S. FREESTONE, D.S. Freestone, DAVID S. FREESTONE, David Freestone

Publications

649

Citations

H-Index

Concepts

All Affiliations

Wellcome Trust Salisbury University

About

D. S. Freestone is an author at Wellcome Trust specializing in medicine, vaccination, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	393
2	Public Health	2	2	34
3	Epidemiology	2	2	27
4	Law	1	1	14
5	Criminal Law	1	1	14

D. S. Freestone

Publications

566

Citations

H-Index

Page 1

	Year	Citations
PREVENTION OF NECROTISING ENTERITIS IN PAPUA NEW GUINEA BY ACTIVE IMMUNISATION Gregory J. Lawrence, Frank Shann, D. S. Freestone, The Lancet VaccinationHealthcare-associated InfectionImmunologyDisease TransmissionInfection Control	1979	82
Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2/Hong Kong/68 (H<sub>3</sub>N<sub>2</sub>) influenza vaccines A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines D. S. Freestone, Stephanie Hamilton-Smith, G. C. Schild, Journal of Hygiene	1972	48
Intranasal Lymphoblastoid Interferon ("Well fer on") Prophylaxis Against Rhinovirus and Influenza Virus in Volunteers R.J. Phillpotts, Paul G. Higgins, J. S. Willman, Journal of Interferon Research	1984	43
Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2/Hong Kong/68 (H3N2) influenza vaccines. D. S. Freestone, Stephanie Hamilton-Smith, G. C. Schild, Epidemiology and Infection VaccinationVaccinologyCross-protectionVaccine DevelopmentDetergent Split	1972	42
Failure of oral 4′, 6-dichloroflavan to protect against rhinovirus infection in man R.J. Phillpotts, John G. Wallace, D. A. J. Tyrrell, Archives of Virology Rhinovirus InfectionAntiviral TherapyVirologyAntiviral DrugOral 4′	1983	40
Vaccination of adults with Wistar RA 27/3 rubella vaccine D. S. Freestone, J. Prydie, Steven G. Smith, Journal of Hygiene	1971	33
RECOMBINANT WRL 105 STRAIN LIVE ATTENUATED INFLUENZA VACCINE C. A. Morris, V.M. Stealey, D. S. Freestone The Lancet VaccinationRecombinant Wrl 105ImmunologyVirologyInfluenza Vaccine	1975	29
Stabilized 17D strain yellow fever vaccine: Dose response studies, clinical reactions and effects on hepatic function D. S. Freestone, R.D. Ferris, A.L. Weinberg, Journal of Biological Standardization VaccinationHepatologyVaccine DevelopmentImmunologyClinical Reactions	1977	29
Failure of intranasally administered 4?, 6-dichloroflavan to protect against rhinovirus infection in man W. Al‐Nakib, J. S. Willman, Paul G. Higgins, Archives of Virology Rhinovirus InfectionMedicineAntiviral TherapyVirologyInfection Control	1987	25
RISK OF EARLY POST-PARTUM PREGNANCY IN CONTEXT OF POST-PARTUM VACCINATION AGAINST RUBELLA J. A. Baldwin, D. S. Freestone The Lancet VaccinationVaccine SafetyMaternal ImmunizationReproductive HealthGynecology	1971	20

Page 1